(Q34461757)

2 August 2017

1 reference

title

Imaging of lung cancer with CT, MRT and PET. (English)

1 reference

2 August 2017

1 reference

Haberkorn U

1

1 reference

2 August 2017

Schoenberg SO

series ordinal

2

1 reference

2 August 2017

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

34 Suppl 3

1 reference

2 August 2017

page(s)

S13-23

1 reference

Improvement of non-small-cell lung cancer staging by means of positron emission tomography

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Simultaneous T2* and diffusion measurements with 3He

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Cancer statistics, 1992

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Mediastinal staging of non-small-cell lung cancer with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Nuclear medicine procedures in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Emerging role of PET in the diagnosis and staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Evaluation of primary pulmonary carcinoid tumors using FDG PET

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Elevation of glucose transporter, c-myc, and transin RNA levels by Ha-rasT24 is independent of its effect on the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Interobserver variation in the computed tomographic evaluation of mediastinal lymph node size in patients with potentially resectable lung cancer. Canadian Lung Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Mediastinal invasion by bronchogenic carcinoma: CT signs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Transformation stimulates glucose transporter gene expression in the absence of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Characterization of chest masses by FDG positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

MRI of the pulmonary parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Contrast-enhanced MRI of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Localized form of bronchioloalveolar carcinoma: FDG PET findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

The number and size of normal mediastinal lymph nodes: a postmortem study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Selective use of PET scan in the preoperative staging of NSCLC

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Enlarged mediastinal lymph nodes in bronchogenic carcinoma: assessment with dynamic contrast-enhanced MR imaging. Work in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Computed tomography in bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Pulmonary abnormalities and PET data analysis: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Prospective investigation of positron emission tomography in lung nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Staging non-small cell lung cancer with whole-body PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Lung cancer and positron emission tomography with fluorodeoxyglucose

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Pulmonary magnetic resonance angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Clinical experience with carinal resection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Regional lymph node classification for lung cancer staging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Chest wall and mediastinal invasion by lung cancer: evaluation with multisection expiratory dynamic CT

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Limitations of CT in evaluation of neoplasms involving chest wall

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Preoperative staging of non-small-cell lung cancer with positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Differentiation of adrenal masses with MR imaging: comparison of techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Glucose uptake by gliomas after treatment. A positron emission tomographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Extrathoracic staging of bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

[Ultrafast MRI phlebography of the lungs]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Resectable stage III lung cancer: CT, surgical, and pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Degradation and biosynthesis of the glucose transporter protein in chicken embryo fibroblasts transformed by the src oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Frequency of extrathoracic metastases from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CT

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

The clinical evaluation for detecting metastatic lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Satellite PET and lung cancer: a prospective study in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Evaluation of lung cancer by 99mTc-tetrofosmin SPECT: comparison with [18F]FDG-PET

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Staging non-small cell lung cancer by whole-body positron emission tomographic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Bronchogenic carcinoma: staging with MR compared with staging with CT and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Transformation by the src oncogene alters glucose transport into rat and chicken cells by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

The src oncogene can regulate a human glucose transporter expressed in chicken embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

Over-expression of facilitative glucose transporter genes in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900369-5

7 January 2021

10.1016/S0169-5002(01)00369-5

Identifiers

DOI

1 reference

2 August 2017

1 reference